Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Long-term high-dose fluconazole can cause reversible hair loss.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

A 38-year-old African American woman has a rare condition that prevents her from growing long hair.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

COVID-19 infection can significantly cause temporary hair loss.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Botulinum toxin injections improved hair thinning in a woman with hair loss.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

COVID-19 may trigger sudden temporary hair loss.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Different patterns on the scalp help diagnose types of hair loss without needing a biopsy.